Trial Outcomes & Findings for Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome (NCT NCT00811590)
NCT ID: NCT00811590
Last Updated: 2024-09-19
Results Overview
Recruitment status
TERMINATED
Study phase
PHASE2
Target enrollment
3 participants
Primary outcome timeframe
24 months
Results posted on
2024-09-19
Participant Flow
Participant milestones
| Measure |
All Patients
All patients enrolled/eligible.
|
|---|---|
|
Overall Study
STARTED
|
3
|
|
Overall Study
COMPLETED
|
3
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
Baseline characteristics by cohort
| Measure |
All Patients
n=3 Participants
All patients enrolled/eligible.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
3 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
34.6667 years
STANDARD_DEVIATION 18.71719 • n=5 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
3 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 24 monthsPopulation: Due to small enrollment number, analysis was not possible.
Outcome measures
Outcome data not reported
Adverse Events
All Patients
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place